GSK vs HBB · P/E 13, $103.31B cap vs P/E 8.3, rev $264.6M
GlaxoSmithKline PLC ADR (GSK) versus Hamilton Beach Brands Holding Co Class A (HBB) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Hamilton Beach Brands Holding Co Class A (HBB) is a furnishings, fixtures & appliances company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported HBB revenue for 2026-06-30 was $264.6M. Net income was $37.2M. HBB currently screens at market cap $273.4M and trailing P/E 8.3.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. HBB currently screens at market cap $273.4M and trailing P/E 8.3.
Not investment advice. Open the GSK and HBB stock pages for the full models.
Not investment advice.